Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

A Jahn, A Rump, T J Widmann, C Heining, P Horak, B Hutter, N Paramasivam, S Uhrig, L Gieldon, S Drukewitz, A Kübler, M Bermudez, K Hackmann, J Porrmann, J Wagner, M Arlt, M Franke, J Fischer, Z Kowalzyk, D WilliamV Weth, S Oster, M Fröhlich, J Hüllein, C Valle González, S Kreutzfeldt, A Mock, C E Heilig, D B Lipka, L Möhrmann, D Hanf, V Teleanu, M Allgäuer, L Ruhnke, O Kutz, A Knurr, A Laßmann, V Endris, O Neumann, R Penzel, K Beck, D Richter, U Winter, S Wolf, K Pfütze, C Geörg, B Meißburger, I Buchhalter, M Augustin, B Klink^*Show 30 moreShow less